🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11795+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11795 recruiting trials

NARecruitingNCT06645587

Targeting Repetitive Behaviors in Autism Spectrum Disorder Via Transcranial Direct Current Stimulation

🏥 Bambino Gesù Hospital and Research Institute📍 1 site📅 Started Oct 2024View details ↗
NARecruitingNCT05561595

Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma

👨‍⚕️ Rebecca Pearl, PhD, University of Florida📍 1 site📅 Started Oct 2024View details ↗
RecruitingNCT05558059

Imaging Retinal Vasculature in Infant Eyes

👨‍⚕️ Xi Chen, MD, Duke University📍 2 sites📅 Started Oct 2024View details ↗
RecruitingNCT06690801

Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome

👨‍⚕️ Anoopindar M Bhalla, MD, Children's Hospital Los Angeles📍 10 sites📅 Started Oct 2024View details ↗
EARLY_Phase 1RecruitingNCT06159504

Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania

👨‍⚕️ Margaret Hellard, Burnet📍 1 site📅 Started Oct 2024View details ↗
NARecruitingNCT06700915

A Clinical Trial to Assess the Efficacy and Tolerance of a Berberine-based Nutraceutical Formula to Aid Blood Sugar Regulation and Metabolism

🏥 Ultimate International, Inc.📍 1 site📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT05947955

Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)

🏥 BioAegis Therapeutics Inc.📍 76 sites📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT06336655

Physiology of Unloading VA ECMO Trial

🏥 University of Utah📍 1 site📅 Started Oct 2024View details ↗
Phase 1, PHASE2Enrolling by InvitationNCT07095686

Personalized Antisense Oligonucleotide for Participants With CHCHD10 ALS

🏥 n-Lorem Foundation📍 1 site📅 Started Oct 2024View details ↗
Phase 3RecruitingNCT06561048

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

👨‍⚕️ Suresh Mahabhashyam, MD, MPH, Corvus Pharmaceuticals, Inc.📍 27 sites📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT06541249

MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial

👨‍⚕️ John Mascarenhas, Icahn School of Medicine at Mount Sinai📍 1 site📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT06490757

A Phase 2 Open-label Single-arm Trial of JAK1 Inhibitor for the Treatment of Large Inflammatory Hepatocellular Adenomas

👨‍⚕️ Jean-Charles NAULT, PUPH, Assistance Publique des Hôpitaux de Paris (APHP)📍 1 site📅 Started Oct 2024View details ↗
NARecruitingNCT06883448

Implementation of Home Monitoring in Patients With Pulmonary Fibrosis

👨‍⚕️ Marlies S. Wijsenbeek-Lourens, Prof Dr, Department of Respiratory Medicine, Center of Excellence for Interstitial Lung Disease, Erasmus University Medical Center, Rotterdam, The Netherlands📍 11 sites📅 Started Oct 2024View details ↗
Phase 1RecruitingNCT06224660

Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy

🏥 Sardocor Corp.📍 3 sites📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT06568237

A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy

👨‍⚕️ Tev Medical Expert, Study Director, Teva Branded Pharmaceutical Products R&D LLC📍 54 sites📅 Started Oct 2024View details ↗
RecruitingNCT06582914

Lynch Syndrome Integrative Epidemiology and Genetics

🏥 University of Colorado, Denver📍 2 sites📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT06663059

Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study

👨‍⚕️ Tao Jiang, Dr, Tangdu hospital, The air force military university📍 1 site📅 Started Oct 2024View details ↗
Phase 1RecruitingNCT06646913

TENS in Scleroderma

🏥 University of Michigan📍 1 site📅 Started Oct 2024View details ↗
Phase 1, PHASE2RecruitingNCT06176027

Azacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell Lymphomas

👨‍⚕️ Liren Qian, PhD, Navy General Hospital, Beijing📍 1 site📅 Started Oct 2024View details ↗
Phase 4Enrolling by InvitationNCT06660329

Efficacy and Safety of Tofacitinib in Refractory Blau Syndrome

🏥 Peking Union Medical College Hospital📍 1 site📅 Started Oct 2024View details ↗
← PreviousPage 227 of 590Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →